+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

S1005 Very Early Viral Response to Treatment of Hepatitis C Virus (Hcv) with Pegylated Interferon and Ribavirin: the First 24 Hours



S1005 Very Early Viral Response to Treatment of Hepatitis C Virus (Hcv) with Pegylated Interferon and Ribavirin: the First 24 Hours



Gastroenterology 134(4): A-773




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067059582

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(08)63610-0


Related references

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load. Journal of Medical Virology 75(1): 27-34, 2005

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan. Intervirology 50(4): 310-315, 2007

Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype. Journal of Gastroenterology and Hepatology 28(3): 443-449, 2013

Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1. Journal of Gastroenterology 49(4): 737-747, 2014

Transcriptomic Microarray Analysis of the Early Response to Treatment of Hepatitis C Virus (Hcv) with Pegylated Interferon and Ribavirin. Gastroenterology 134(4): A-753, 2008

Achievement of sustained viral response after switching treatment from pegylated interferon α-2b to α-2a and ribavirin in patients with recurrence of hepatitis C virus genotype 1 infection after liver transplantation: a case report. Intervirology 55(4): 306-310, 2012

Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks. Hepatology Research 44(2): 179-186, 2014

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 49(6): 1847-1858, 2009

Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia. Intervirology 50(5): 361-368, 2007

Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: prospective, non-randomized study. Journal of Gastroenterology and Hepatology 23(6): 861-866, 2008

Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C. Revista Espanola de Enfermedades Digestivas 101(10): 665-670, 2009

Viral kinetics and early prediction of non-response to pegylated interferon/ribavirin in HIV infected patients with genotypes 1/4-related chronic hepatitis C. Hepatology 38(4 Suppl 1): 749A, 2003

Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response. Hepatology Research 39(8): 753-759, 2009

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection. Hepatology 56(5): 1611-1621, 2012

Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads. Digestive Diseases and Sciences 54(6): 1317-1324, 2009